|
|
||||||||
1 British Biotech Pharmaceuticals Ltd, Watlington Road, Oxford OX4 5LY
2 Rhone Merieux Ltd, Pirbright, Surrey GU24 0NQ
3 Institute for Animal Health, Compton, Berkshire RG16 0NN
4 Division of Cell and Molecular Biology, University of St Andrews, Fife KY16 9AL
and5 Institute for Animal Health, Pirbright, Surrey GU24 0NF, UK
The role of T cells in immunity to foot-and-mouth disease virus is still poorly defined compared to that of the humoral response. In this paper we describe a systematic, longitudinal study on the cellular recognition of FMDV and its subunit protein VP1 by bovine peripheral blood T lymphocytes. Multiple vaccination with a single virus serotype induced a serotype cross-reactive proliferative T cell repertoire that varied in magnitude between individual animals and with the serotype of the vaccine used. Primary proliferative T cell responses of vaccinated and acutely infected cattle were weak relative to the magnitude of responses determined for the same animals after boosting. In contrast, the level of circulating antibody produced after both primary and secondary exposure to virus was good. Phenotypic analysis of lymphocytes from vaccinated or infected cattle showed a small increase in CD8+ T cells after infection compared to vaccination. However, in general the profiles of circulating lymphocytes elicited were similar. Thus, we were not able to use proliferative or phenotypic analyses to distinguish between vaccinated and convalescent cattle. T cell recognition of VP1 by multiply-vaccinated cattle was serotype-specific implying that the cross-reactive responses observed with whole virus may be attributed to proteins other than VP1. In contrast to other studies, immunization with recombinant VP1 induced only low levels of neutralizing antibody and failed to elicit profound proliferative responses or protection even after two immunizations.
* Author for correspondence. Fax +44 1865 781115.
Received 2 October 1995;
accepted 13 December 1995.
This article has been cited by other articles:
![]() |
M. Y. Gulbahar, W. C. Davis, T. Guvenc, M. Yarim, U. Parlak, and Y. B. Kabak Myocarditis Associated with Foot-and-Mouth Disease Virus Type O in Lambs Vet. Pathol., September 1, 2007; 44(5): 589 - 599. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ostrowski, M. Vermeulen, O. Zabal, P. I. Zamorano, A. M. Sadir, J. R. Geffner, and O. J. Lopez The Early Protective Thymus-Independent Antibody Response to Foot-and-Mouth Disease Virus Is Mediated by Splenic CD9+ B Lymphocytes J. Virol., September 1, 2007; 81(17): 9357 - 9367. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Grubman and B. Baxt Foot-and-Mouth Disease Clin. Microbiol. Rev., April 1, 2004; 17(2): 465 - 493. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Cedillo-Barron, M. Foster-Cuevas, G. J. Belsham, F. Lefevre, and R. M. E. Parkhouse Induction of a protective response in swine vaccinated with DNA encoding foot-and-mouth disease virus empty capsid proteins and the 3D RNA polymerase J. Gen. Virol., July 1, 2001; 82(7): 1713 - 1724. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Blanco, K. McCullough, A. Summerfield, J. Fiorini, D. Andreu, C. Chiva, E. Borrás, P. Barnett, and F. Sobrino Interspecies Major Histocompatibility Complex-Restricted Th Cell Epitope on Foot-and-Mouth Disease Virus Capsid Protein VP4 J. Virol., May 15, 2000; 74(10): 4902 - 4907. [Abstract] [Full Text] |
||||
![]() |
M. D. Baron, M. Foster-Cuevas, J. Baron, and T. Barrett Expression in cattle of epitopes of a heterologous virus using a recombinant rinderpest virus J. Gen. Virol., August 1, 1999; 80(8): 2031 - 2039. [Abstract] [Full Text] |
||||
![]() |
A. Childerstone, L Cedillo-Baron, M Foster-Cuevas, and R. Parkhouse Demonstration of bovine CD8+ T-cell responses to foot-and-mouth disease virus J. Gen. Virol., March 1, 1999; 80(3): 663 - 669. [Abstract] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |